193 related articles for article (PubMed ID: 23959795)
1. Treg vaccination in autoimmune type 1 diabetes.
Serr I; Weigmann B; Franke RK; Daniel C
BioDrugs; 2014 Feb; 28(1):7-16. PubMed ID: 23959795
[TBL] [Abstract][Full Text] [Related]
2. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
[TBL] [Abstract][Full Text] [Related]
3. Self-Transducible Bimodal PDX1-FOXP3 Protein Lifts Insulin Secretion and Curbs Autoimmunity, Boosting Tregs in Type 1 Diabetic Mice.
Amatya C; Radichev IA; Ellefson J; Williams M; Savinov AY
Mol Ther; 2018 Jan; 26(1):184-198. PubMed ID: 28988715
[TBL] [Abstract][Full Text] [Related]
4. Treg vaccination with a strong-agonistic insulin mimetope.
Weigmann B; Daniel C
Curr Diab Rep; 2012 Oct; 12(5):463-70. PubMed ID: 22763731
[TBL] [Abstract][Full Text] [Related]
5. Role of regulatory T cells for the treatment of type 1 diabetes mellitus.
Jaeckel E; Mpofu N; Saal N; Manns MP
Horm Metab Res; 2008 Feb; 40(2):126-36. PubMed ID: 18283631
[TBL] [Abstract][Full Text] [Related]
6. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
7. Extrathymic generation of regulatory T cells--chances and challenges for prevention of autoimmune disease.
Daniel C; von Boehmer H
Adv Immunol; 2011; 112():177-213. PubMed ID: 22118409
[TBL] [Abstract][Full Text] [Related]
8. Exploring the induction of preproinsulin-specific Foxp3(+) CD4(+) Treg cells that inhibit CD8(+) T cell-mediated autoimmune diabetes by DNA vaccination.
Stifter K; Schuster C; Schlosser M; Boehm BO; Schirmbeck R
Sci Rep; 2016 Jul; 6():29419. PubMed ID: 27406624
[TBL] [Abstract][Full Text] [Related]
9. Are Regulatory T Cells Defective in Type 1 Diabetes and Can We Fix Them?
Visperas A; Vignali DA
J Immunol; 2016 Nov; 197(10):3762-3770. PubMed ID: 27815439
[TBL] [Abstract][Full Text] [Related]
10. Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.
You S; Leforban B; Garcia C; Bach JF; Bluestone JA; Chatenoud L
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6335-40. PubMed ID: 17389382
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy in autoimmune type 1 diabetes.
Weigmann B; Franke RK; Daniel C
Rev Diabet Stud; 2012; 9(2-3):68-81. PubMed ID: 23403703
[TBL] [Abstract][Full Text] [Related]
12. Analyses of regulatory CD4+ CD25+ FOXP3+ T cells and observations from peripheral T cell subpopulation markers during the development of type 1 diabetes in children.
Hamari S; Kirveskoski T; Glumoff V; Kulmala P; Simell O; Knip M; Veijola R
Scand J Immunol; 2016 Apr; 83(4):279-87. PubMed ID: 26888215
[TBL] [Abstract][Full Text] [Related]
13. Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes.
Li CR; Baaten BJ; Bradley LM
J Mol Cell Biol; 2012 Feb; 4(1):38-47. PubMed ID: 22116888
[TBL] [Abstract][Full Text] [Related]
14. Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I diabetes.
Kornete M; Piccirillo CA
Autoimmun Rev; 2011 Dec; 11(2):104-11. PubMed ID: 21875694
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin attenuates airway inflammation through induction of forkhead box protein 3-positive regulatory T cells.
Massoud AH; Guay J; Shalaby KH; Bjur E; Ablona A; Chan D; Nouhi Y; McCusker CT; Mourad MW; Piccirillo CA; Mazer BD
J Allergy Clin Immunol; 2012 Jun; 129(6):1656-65.e3. PubMed ID: 22564681
[TBL] [Abstract][Full Text] [Related]
16. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
17. CD4+Foxp3+ regulatory T cells in the control of autoimmunity: in vivo veritas.
Piccirillo CA; d'Hennezel E; Sgouroudis E; Yurchenko E
Curr Opin Immunol; 2008 Dec; 20(6):655-62. PubMed ID: 18926906
[TBL] [Abstract][Full Text] [Related]
18. Tolerogenic vaccination reduced effector memory CD4 T cells and induced effector memory Treg cells for type I diabetes treatment.
Zhang J; Gao W; Yang X; Kang J; Zhang Y; Guo Q; Hu Y; Xia G; Kang Y
PLoS One; 2013; 8(7):e70056. PubMed ID: 23894591
[TBL] [Abstract][Full Text] [Related]
19. Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective.
Yu H; Paiva R; Flavell RA
Immunology; 2018 Feb; 153(2):161-170. PubMed ID: 29155454
[TBL] [Abstract][Full Text] [Related]
20. Prevention of type 1 diabetes in mice by tolerogenic vaccination with a strong agonist insulin mimetope.
Daniel C; Weigmann B; Bronson R; von Boehmer H
J Exp Med; 2011 Jul; 208(7):1501-10. PubMed ID: 21690251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
